Zimmer Biomet Inc.
ZBH | NYSE
$94.32
-$1.04 (-1.09%)
At close: Sep 21, 2026, 4:00 PM ET
$94
-$0.32 (-0.34%)
Pre-market:
Sep 22, 2026, 4:14 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 8.23B | 7.68B | 7.39B | 6.94B | 6.83B | 6.13B |
Cost of Revenue | 3.16B | 2.19B | 2.08B | 2.02B | 1.96B | 1.82B |
Gross Profit | 5.07B | 5.49B | 5.31B | 4.92B | 4.87B | 4.3B |
Operating Income | 1.36B | 1.29B | 1.28B | 696.3M | 860.3M | 83.1M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 830.8M | 1.04B | 1.07B | 403.5M | 499M | -105.2M |
Net Income | 705.2M | 903.8M | 1.02B | 231.4M | 401.6M | -138.9M |
Selling & General & Admin | 3.25B | 2.93B | 2.84B | 2.76B | 2.84B | 2.71B |
Research & Development | 458.5M | 437.4M | 458.7M | 406M | 435.8M | 322.8M |
Other Expenses | n/a | 834.5M | 735.1M | 1.06B | 727.4M | 1.18B |
Operating Expenses | 3.71B | 4.2B | 4.03B | 4.22B | 4.01B | 4.22B |
Interest Expense | 292.8M | 218M | 201.2M | 164.8M | 208.4M | 212.1M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.87B | 6.39B | 6.12B | 6.24B | 5.97B | 6.04B |
Income Tax Expense | 125.7M | 131.4M | 42.2M | 112.3M | 53.5M | -96M |
Shares Outstanding (Basic) | 198M | 203.1M | 208.7M | 209.6M | 208.6M | 207M |
Shares Outstanding (Diluted) | 198.7M | 203.9M | 209.7M | 210.3M | 210.4M | 207M |
EPS (Basic) | 3.56 | 4.45 | 4.91 | 1.10 | 1.93 | -0.67 |
EPS (Diluted) | 3.55 | 4.43 | 4.88 | 1.10 | 1.91 | -0.67 |
EBITDA | 2.22B | 2.25B | 2.22B | 1.49B | 1.65B | 1.01B |
EBIT | 1.12B | 1.25B | 1.27B | 568.3M | 707.4M | 106.9M |
Depreciation & Amortization | 1.09B | 996.3M | 951.7M | 926.4M | 937.7M | 898.4M |
Add to Watchlist
Select watchlists to add or remove ZBH